Evaluating the PCOS risk algorithm (PriskA): a pilot study
Authors:
Open Access
- 27 February 2026
- journal article
- research article
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 19 (1)
Abstract
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder with reproductive, metabolic, and psychological features, often underdiagnosed due to diagnostKeywords
Funding Information
- Roche Diagnostics International Ltd
This publication has 26 references indexed in Scilit:
- Prospective validation of anti-Müllerian hormone cutoff to determine polycystic ovarian morphology: HARMONIA studyFertility and Sterility, 2025
- Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysisFertility and Sterility, 2024
- Exploring the dominant features and data-driven detection of polycystic ovary syndrome through modified stacking ensemble machine learning techniqueHeliyon, 2023
- Antimüllerian hormone to determine polycystic ovarian morphologyFertility and Sterility, 2021
- Increased prevalence of eating disorders, low self-esteem, and psychological distress in women with polycystic ovary syndrome: a community-based cohort studyFertility and Sterility, 2019
- Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndromeFertility and Sterility, 2018
- Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysisFertility and Sterility, 2016
- Criteria, prevalence, and phenotypes of polycystic ovary syndromeFertility and Sterility, 2016
- Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United StatesFertility and Sterility, 2011
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004